Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It d…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Transactions 2026-05-05 Financing
Report of exempt distribution (45-106F1) (amended).pdf
Results 2026-05-01
Annual MD&A - English.pdf
Results 2026-05-01
Audited annual financial statements – English.pdf
Transactions 2026-03-06 M&A
Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives
News release - English.pdf
News 2025-12-08
Report of exempt distribution (45-106F1).pdf
Transactions 2025-11-28 Financing
Cytophage Announces Closing of Non-Brokered Private Placement and Filing of Q3 Financials
News release - English.pdf
Results 2025-11-28 Financials
Interim financial statements/report – English.pdf
Results 2025-11-28 Financials
Interim MD&A - English.pdf
News 2025-11-20
Report of exempt distribution (45-106F1).pdf
News 2025-11-13
News release - English.pdf
News 2025-11-05
News release - English.pdf
News 2025-10-17
News release - English.pdf
News 2025-10-16
News release - English.pdf
News 2025-09-29
News release - English.pdf
News 2025-09-23
News release - English.pdf
News 2025-09-15
Report of exempt distribution (45-106F1) (amended).pdf
News 2025-09-11
News release - English.pdf
Results 2025-08-29 Financials
Interim MD&A - English.pdf
Results 2025-08-29 Financials
Interim financial statements/report – English.pdf
News 2025-08-25
News release - English.pdf
News 2025-08-01
News release - English.pdf
News 2025-07-28
News release - English.pdf
News 2025-06-19
Report of exempt distribution (45-106F1).pdf